肿瘤生物学与转化医学.ppt

Then the anti-metastasis and recurrence effect of LICARTIN was determined in the post-orthotopic liver transplantation (OLT) HCC patients. Our initial results showed that LICARTIN significantly decreased recurrence rate and increased survival rate of HCC patients, compared with untreated control group. So LICARTIN is a promising new anti-metastasis and recurrence agent for treating HCC. Problems of Cancer Biomarker No cancer biomarker is absolutely specific No cancer biomarker test is free of false negatives No cancer biomarker test is free of false positives No cancer biomarker is absolutely